19 - 21 June 2018 |
Zurich, Switzerland

Media Center


Software Best Practises: Implementation & Data Integration

Effective data management is imperative to achieve regulatory compliance with a serialisation programme. Non-standard data exchange and integration methods are seen as one of the biggest hurdles in serialisation compliance.4

In light of the data responsibilities expected within serialisation projects, Pharma IQ consults with a selection of experts on software best practices - data integration and implementation.

Serialisation Track and Trace Map 2017

The global pharmaceutical industry is moving towards a serialised world. In over 40 countries, regulatory mandates to secure the supply chain are already in place or in development. Download our printable map to see an overview of various nations’ progress in their serialisation journey.

Case Studies:The SME and CMO Perspectives

Pharma IQ spoke to Mark Davison, Chief Executive Officer at Blue Sphere Health Ltd to gain insight on his experience working with SME pharma & biotechs for serialisation. Also we spoke to Vetter pharma – a responsible CMO for their insight on how peer CMOs optimise their serialisation strategy.

2017 Industry Trend Report

This year’s research report maps out and measures the changes in consensus as the industry advances closer to an entirely track and traced pharmaceutical environment.

Download to view the results of the 2016 report. 

Pharma Serialisation Agenda Road Map

No matter where you are in your serialisation journey the 7th Annual Pharmaceutical Serialisation & Traceability Summit has all the information you need. Topics ranging from early implementation all the way to implementing your level 4 communication strategy.

Serialisation Implementation Timeline

In the absence of a one-size-fits all-approach, after consulting with industry experts, Pharma IQ proposes this framework for key milestones within a sustainable serialisation strategy - in which firms can choose customize in relevance to their requirements.

Serialisation: Top Tech Integration Considerations

Roger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone.

Undoubtedly, technology stands as a keystone in a controlled track and trace system.

In this eBook we look at the key considerations organisations face in finding the right technologies and focus on the strategies for integration to ensure a successful serialisation project.


Acceleration, Optimisation and Beyond Compliance

As many pharmaceutical manufactures and CMOs are scrambling to implement serialisation and traceability technologies to comply with regulatory mandates, others are simultaneously exploring how these systems can actually go further than compliance - to improve supply chain planning and operations, speed up product recalls, and improve sales and marketing strategies. Pharma IQ spoke with experts in the industry to discuss moving beyond compliance in serialisation and their predictions as to how successful the regulations will be at reducing the presence of counterfeit pharmaceuticals on an international scale.

The Final Stages of Serialisation

Ahead of the Serialisation and Traceability Summit 2017 we conducted extensive market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation.


Serialisation 2015 - What's next for the market?

Pharma IQ spoke to Jean Marc Bobee of Sanofi to find out about what’s next for the market in terms of serialisation.

Serialisation: The South Korean Landscape

Pharma IQ spoke to Jay Jay Han of Hanmi Pharmaceutical to explore the serialisation landscape in South Korea.

On Site at Serialisation 2015

Pharma IQ talks to some of the attendees at Serialisation & Traceability 2015 to gain their thoughts on the conference


Serialisation Track and Trace Map 2017

The global pharmaceutical industry is moving towards a serialised world. In over 40 countries, regulatory mandates to secure the supply chain are already in place or in development. Download our printable map to see an overview of various nations’ progress in their serialisation journey.


New for 2016: Printable Worldmap - Serialisation Deadlines

As the serialisation industry prepares for various approaching deadlines all over the globe, Pharma IQ has created a printable map to assist with your worldwide track and trace compliance strategies.

10 Tips for Developing a Serialisation Strategy: Your Roadmap to Success!

The serialisation strategy of a company and the resultant serialisation service that delivers and maintains the capabilities required, needs to ensure that the requirements of legislation are understood and the capabilities are defined to meet those needs. Once serialisation capabilities become available, companies can then look to leverage them for product security and other benefits that are not directly driven by legislation. Pharma IQ presents a series of 10 tips for developing and implementing your serialisation strategy.

Traceability in Operation Market Research: Concerns and Priorities

Ahead of the Traceability In Operation forum 2017 Pharma IQ conducted some market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability.

Exclusive: Interview On GS1’s Traceability Guideline for Brazil

After around six months of consultation, global standards organisation GS1 is in the final stages of compiling its Brazilian Medicine Traceability using GS1 EPCIS Part 1 Implementation Guide.

In the lead up to this hotly anticipated document, Pharma IQ spoke to Eduardo Salles, Director da Dotter do Brazil who assisted with the creation of this GS1 file.

Industry Report: Global Traceability and Serialisation Pharma

In this Serialisation Report, Pharma IQ presents the findings of its latest industry survey while drawing trends on previous years to explore the shifts in industry consensus. Plus, Pharma IQ presents its printable Serialisation Deadline Worldmap.


Serialisation, Track & Trace and e-Pedigree for Pharma

Sebastien Mauel, Head of Product Security, Merck Serono, shares his insights with Pharma IQ at IQPC's Pharmaceutical Serialisation & Traceability event. Mauel discusses the current challenges relating to detecting counterfeit drugs in the supply chain, preventing counterfeiting at the pharmacy, strategies for successful authentication of pharmaceutical products and the benefits and pitfalls of the e-pedigree approach.

Serialisation, Traceability and Coding – Responding as a Pharmaceutical Company to the Challenges

In this presentation Christoph Krähenbühl, IS Programme Manager, Pack Coding and Product Security, AstraZeneca discusses product security, patient safety, anti-counterfeiting, supply chain control and coding. He also discussed how AstraZeneca tackles some of these issues.


A One Page Guide to Drug Supply Chain Security Act (DSCSA)

Pharma IQ presents this interactive one page guide to the Drug Supply Chain Security Act (DSCSA) Implementation Plan

Pharmaceutical Serialization & Traceability 2017 Market Research

The end of 2017 is peppered with compliance deadlines for the track and trace industry as it joins the combat against counterfeit pharmaceuticals. These regions include the likes of Canada, the US and Ukraine. Despite the urgency, many medicine manufacturers in the industry have been labelled as behind schedule. With time running low, take a look at Pharma IQ’s 2017 serialization research and benchmark where you sit in the race. Shortly we will be releasing indepth analysis on these findings with help from industry experts.

Managing Serialisation – Authentication and Track and Trace

In this article we will discuss publishing the related serialisation information and two of the common serialisation models, Authentication and Track and Trace. Product Information Notification Typically, once product packaging of one or more levels has been uniquely identified, this information, together with other information related to the product and manufacturer is passed to an external agency database. 

Tackling the Challenge of Serialisation and Traceability

As counterfeit drug sales become increasingly costly to both pharmaceutical manufacturers and patients, companies are attempting to address the challenges of serialisation and traceability to reduce the burden on health services across the world.

Drug Quality and Security Act- New US Legislation for Pharma Tracking

Don’t be distracted by news of a ‘shutdown’ in the American government, some of the biggest news from the pharmaceutical legislation perspective is not related to the inability to pass a budget. The Drug Quality and Security Act will have a bigger impact on pharma.


Pharmaceutical Serialisation - The Global Problem with No Global Solution

In this Pharma IQ interview Pasi Kemppainen, executive consultant for serialisation and traceability and current lead of serialisation implementation at Orion Pharma, shares his insights on why the pharmaceutical industry has been slow to adopt mass serialisation, key implementation challenges and preparing for regulation requirements in the future.

Pasi Kemppainen on Managing & Implementing Pharmaceutical Serialisation

Pasi Kemppainen is an executive consultant for serialisation and traceability and currently leading the serialisation implementation at Orion Pharma. In this interview he speaks to Andrea Charles from Pharma IQ, about managing and implementing serialisation and shares his top tip for preparing  for regulation requirements and implementation in the future.